1. Home
  2. Labeler Index
  3. Astellas Pharma Us, Inc.
  4. 0469-2660
  5. NDC Package Code: 0469-2660-90 Veozah

NDC Package 0469-2660-90 Veozah

Fezolinetant Tablet, Film Coated Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0469-2660-90
Package Description:
1 BOTTLE in 1 CARTON / 90 TABLET, FILM COATED in 1 BOTTLE
Product Code:
0469-2660
Proprietary Name:
Veozah
Non-Proprietary Name:
Fezolinetant
Substance Name:
Fezolinetant
Usage Information:
VEOZAH™ is indicated for the treatment of moderate to severe vasomotor symptoms due to menopause.
11-Digit NDC Billing Format:
00469266090
NDC to RxNorm Crosswalk:
  • RxCUI: 2637141 - fezolinetant 45 MG Oral Tablet
  • RxCUI: 2637147 - VEOZAH 45 MG Oral Tablet
  • RxCUI: 2637147 - fezolinetant 45 MG Oral Tablet [Veozah]
  • RxCUI: 2637147 - Veozah 45 MG Oral Tablet
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Astellas Pharma Us, Inc.
    Dosage Form:
    Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • FEZOLINETANT 45 mg/1
    • Sample Package:
    No
    FDA Application Number:
    NDA216578
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    05-12-2023
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    0469-2660-301 BOTTLE in 1 CARTON / 30 TABLET, FILM COATED in 1 BOTTLE

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0469-2660-90?

    The NDC Packaged Code 0469-2660-90 is assigned to a package of 1 bottle in 1 carton / 90 tablet, film coated in 1 bottle of Veozah, a human prescription drug labeled by Astellas Pharma Us, Inc.. The product's dosage form is tablet, film coated and is administered via oral form.

    Is NDC 0469-2660 included in the NDC Directory?

    Yes, Veozah with product code 0469-2660 is active and included in the NDC Directory. The product was first marketed by Astellas Pharma Us, Inc. on May 12, 2023 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 0469-2660-90?

    The 11-digit format is 00469266090. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20469-2660-905-4-200469-2660-90